MoneyWorks4Me

Ganga Pharmaceuticals informs about outcome of board meeting

22 May 2017 Evaluate

Ganga Pharmaceuticals has informed that the Board of Directors of Company at its meeting held on May 22, 2017, has considered and adopted the Audited Financial Results for the half year/year ended March 31, 2017.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1753.95
Dr. Reddys Labs. 1239.00
Cipla 1329.90
Lupin 1928.00
Zydus Lifesciences 1135.00
View more..